Literature DB >> 14601027

Genomic scan of 254 hereditary prostate cancer families.

Marta Janer1, Danielle M Friedrichsen, Janet L Stanford, Michael D Badzioch, Suzanne Kolb, Kerry Deutsch, Mette A Peters, Ellen L Goode, Russ Welti, Hawkins B DeFrance, Lori Iwasaki, Sarah Li, Leroy Hood, Elaine A Ostrander, Gail P Jarvik.   

Abstract

Hereditary prostate cancer (HPC) is a genetically heterogeneous disease, complicating efforts to map and clone susceptibility loci. We have used stratification of a large dataset of 254 HPC families in an effort to improve power to detect HPC loci and to understand what types of family features may improve locus identification. The strongest result is that of a dominant locus at 6p22.3 (heterogeneity LOD (HLOD) = 2.51), the evidence for which is increased by consideration of the age of PC onset (HLOD = 3.43 in 214 families with median age-of-onset 56-72 years) and co-occurrence of primary brain cancer (HLOD = 2.34 in 21 families) in the families. Additional regions for which we observe modest evidence for linkage include chromosome 7q and 17p. Only weak evidence of several previously implicated HPC regions is detected. These analyses support the existence of multiple HPC loci, whose presence may be best identified by analyses of large, including pooled, datasets which consider locus heterogeneity. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14601027     DOI: 10.1002/pros.10305

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  26 in total

1.  Identification of a prostate cancer susceptibility locus on chromosome 7q11-21 in Jewish families.

Authors:  Danielle M Friedrichsen; Janet L Stanford; Sarah D Isaacs; Marta Janer; Bao-Li Chang; Kerry Deutsch; Elizabeth Gillanders; Suzanne Kolb; Katherine E Wiley; Michael D Badzioch; S Lilly Zheng; Patrick C Walsh; Gail P Jarvik; Leroy Hood; Jeffrey M Trent; William B Isaacs; Elaine A Ostrander; Jianfeng Xu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

2.  The zinc finger transcription factor ZKSCAN3 promotes prostate cancer cell migration.

Authors:  Xingding Zhang; Yu Jing; Yang Qin; Sally Hunsucker; Huimin Meng; Jun Sui; Yelin Jiang; Li Gao; Gangli An; Nan Yang; Robert Z Orlowski; Lin Yang
Journal:  Int J Biochem Cell Biol       Date:  2012-04-16       Impact factor: 5.085

3.  Two-locus genome-wide linkage scan for prostate cancer susceptibility genes with an interaction effect.

Authors:  Bao-Li Chang; Ethan M Lange; Latchezar Dimitrov; Christopher J Valis; Elizabeth M Gillanders; Leslie A Lange; Kathleen E Wiley; Sarah D Isaacs; Fredrik Wiklund; Agnes Baffoe-Bonnie; Carl D Langefeld; S Lilly Zheng; Mika P Matikainen; Tarja Ikonen; Henna Fredriksson; Teuvo Tammela; Patrick C Walsh; Joan E Bailey-Wilson; Johanna Schleutker; Henrik Gronberg; Kathleen A Cooney; William B Isaacs; Edward Suh; Jeffrey M Trent; Jianfeng Xu
Journal:  Hum Genet       Date:  2005-11-23       Impact factor: 4.132

Review 4.  Prostate cancer susceptibility loci: finding the genes.

Authors:  Elanie A Ostrander; Bo Johannesson
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

5.  Genome-wide linkage scan of prostate cancer Gleason score and confirmation of chromosome 19q.

Authors:  Daniel J Schaid; Janet L Stanford; Shannon K McDonnell; Miia Suuriniemi; Laura McIntosh; Danielle M Karyadi; Erin E Carlson; Kerry Deutsch; Marta Janer; Lee Hood; Elaine A Ostrander
Journal:  Hum Genet       Date:  2007-05-08       Impact factor: 4.132

6.  Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation.

Authors:  Erica S Rinella; Yongzhao Shao; Lauren Yackowski; Sreemanta Pramanik; Ruth Oratz; Freya Schnabel; Saurav Guha; Charles LeDuc; Christopher L Campbell; Susan D Klugman; Mary Beth Terry; Ruby T Senie; Irene L Andrulis; Mary Daly; Esther M John; Daniel Roses; Wendy K Chung; Harry Ostrer
Journal:  Hum Genet       Date:  2013-01-25       Impact factor: 4.132

Review 7.  The role of the BRCA2 gene in susceptibility to prostate cancer revisited.

Authors:  Elaine A Ostrander; Miriam S Udler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-08       Impact factor: 4.254

8.  Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer.

Authors:  Marc D Tischkowitz; Ahmet Yilmaz; Long Q Chen; Danielle M Karyadi; David Novak; Tomas Kirchhoff; Nancy Hamel; Sean V Tavtigian; Suzanne Kolb; Tarek A Bismar; Raquel Aloyz; Peter S Nelson; Lee Hood; Steven A Narod; Kirsten A White; Elaine A Ostrander; William B Isaacs; Kenneth Offit; Kathleen A Cooney; Janet L Stanford; William D Foulkes
Journal:  Cancer Lett       Date:  2008-06-20       Impact factor: 8.679

9.  Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb.

Authors:  Bo Johanneson; Shannon K McDonnell; Danielle M Karyadi; Scott J Hebbring; Liang Wang; Kerry Deutsch; Laura McIntosh; Erika M Kwon; Miia Suuriniemi; Janet L Stanford; Daniel J Schaid; Elaine A Ostrander; Stephen N Thibodeau
Journal:  Hum Genet       Date:  2007-12-08       Impact factor: 4.132

10.  Searching for epistasis and linkage heterogeneity by correlations of pedigree-specific linkage scores.

Authors:  Daniel J Schaid; Shannon K McDonnell; Erin E Carlson; Stephen N Thibodeau; Janet L Stanford; Elaine A Ostrander
Journal:  Genet Epidemiol       Date:  2008-07       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.